Anya K Bershad, MD
Psychiatry · Los Angeles
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 7 years
- University of Chicago, Pritzker School of Medicine, 2019
Offices
2 locations · UC Regents · 148 clinicians in this group
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bershad’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A180915 · Current
Licensed to practise in California · since 2022 · expires 2028-09-30 · University of Chicago, Pritzker School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Psychiatry and Neurology - Psychiatry
Original Medicare doctor bills
$5,561
Medicare paid this office $5,561 for 47 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 35 | $3,986 | $87 |
Who their Medicare patients are
47 Original Medicare patients in 2024. Average age 50 · Women 47% · Health risk score 1.29. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 43% · High blood pressure 38% · Diabetes 26%.
The office billed $50,802, Medicare allowed $8,308 and paid $5,561; for 66 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their 145 Part D prescriptions in 2022.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2022 | 145 | 11 | 0% (0) | None | $11,624 |
| 2021 | 96 | 12 | 0% (0) | None | $4,187 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2022: 6 drugs
| Aripiprazole | 15 | $4,133 | $276 |
| Quetiapine | 14 | $551 | $39 |
| Bupropion Xl | 15 | $533 | $36 |
| Clozapine | 12 | $351 | $29 |
| Duloxetine | 14 | $239 | $17 |
| Modafinil | 14 | $238 | $17 |
2021: 1 drug
| Duloxetine | 11 | $105 | $10 |
Money from drug and device companies
$112 in 2025
| 2025 | 1 | 1 | None | $112 |
| 2023 | 1 | 1 | None | $32 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Cobenfy | $112 | 1 payment
|
See the published payment
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-15 | Cobenfy | $112 |
See earlier years (2023)
2023: $32
| Otsuka Pharmaceutical Development & Commercialization | Rexulti | $32 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.7 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265993059
- Licence
- CA A180915California A180915: Current · expires 2028-09-30
- Trained
- University of Chicago, Pritzker School of Medicine, 2019 · 7 years ago
- Group
- UC Regents
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 5767 W Century Blvd Ste 400, Los Angeles, CA, 90045
- NPI first listed
- 2019-03-26
- NPI last updated
- 2024-07-19
- NPI record certified
- 2024-07-19
This is when the NPI record was last certified, not a medical board exam.